IQVIA stock rating downgraded to Hold by TD Cowen, price target raised

Published 03/11/2025, 12:42
IQVIA stock rating downgraded to Hold by TD Cowen, price target raised

Investing.com - TD Cowen downgraded IQVIA Holdings (NYSE:IQV) from Buy to Hold on Monday, while raising its price target to $215.00 from $206.00. The current stock price of $216.46 sits just above this new target, with IQVIA trading near its 52-week high of $225.91.

The research firm cited valuation concerns as the primary reason for the downgrade, noting that IQVIA’s current valuation of 17 times 2026 adjusted earnings per share largely reflects the company’s growth outlook. The stock currently trades at a P/E ratio of 29.64, though InvestingPro data shows the company is slightly undervalued based on Fair Value estimates.

TD Cowen acknowledged improved visibility and stability in IQVIA’s outlook but expressed caution about the company’s potential for further upside in 2026.

The firm specifically pointed to "generally subdued market conditions and margin pressures" as factors limiting room for additional growth beyond current projections.

IQVIA is expected to deliver mid-single-digit percentage topline growth and high-single-digit percentage adjusted EPS growth in 2026, according to TD Cowen’s analysis.

In other recent news, IQVIA Holdings reported its third-quarter earnings for 2025, surpassing analyst expectations. The company achieved an adjusted diluted EPS of $3.00, slightly above the forecast of $2.97. Revenue for the quarter reached $4.1 billion, exceeding the expected $4.08 billion. Despite these positive results, the stock experienced a pre-market decline, indicating cautious market sentiment. Additionally, Baird upgraded IQVIA Holdings’ stock rating from Neutral to Outperform. The research firm raised its price target to $258.00 from $224.00, citing a moderately improving environment in the clinical and commercial research and development sector. These developments highlight recent activities surrounding IQVIA Holdings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.